Lineage, Inc. Common Stock (LINE)vsSeritage Growth Properties (SRG)
LINE
Lineage, Inc. Common Stock
$35.99
-1.64%
REAL ESTATE · Cap: $8.93B
SRG
Seritage Growth Properties
$2.55
-2.30%
REAL ESTATE · Cap: $143.63M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 25851% more annual revenue ($5.36B vs $20.64M). SRG leads profitability with a 0.0% profit margin vs -1.9%. SRG earns a higher WallStSmart Score of 36/100 (F).
LINE
Hold36
out of 100
Grade: F
SRG
Hold36
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+75.9%
Fair Value
$161.49
Current Price
$35.99
$125.50 discount
Margin of Safety
+10.6%
Fair Value
$3.40
Current Price
$2.55
$0.85 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Revenue surging 231.1% year-over-year
Areas to Watch
0.0% earnings growth
ROE of -1.2% — below average capital efficiency
Revenue declined 0.2%
Distress zone — elevated risk
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -18.5% — below average capital efficiency
Earnings declined 97.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : SRG
The strongest argument for SRG centers on Price/Book, Revenue Growth. Revenue growth of 231.1% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.
Bear Case : SRG
The primary concerns for SRG are Market Cap, Profit Margin, Return on Equity.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while SRG is a hypergrowth play — different risk/reward profiles.
SRG is growing revenue faster at 231.1% — sustainability is the question.
LINE generates stronger free cash flow (78M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LINE scores higher overall (36/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.
Visit Website →Seritage Growth Properties
REAL ESTATE · REAL ESTATE SERVICES · USA
Seritage Growth Properties is a publicly traded, self-managed and self-managed REIT with 166 wholly owned properties and 29 unconsolidated properties totaling approximately 30.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?